On the upside
Aeterna Zentaris (Nasdaq: AEZS) reported upbeat results from a Phase 1 clinical study of its cancer treatment AEZS-112.
Investors are optimistic that the government will restructure American International Group's (Nasdaq: AIG) bailout package.
Raymond James analyst Budd Bugatch affirmed his Strong Buy rating for Pier 1 Imports (NYSE: PIR).
On the downside
Nasdaq sent Repros Therapeutics (Nasdaq: RPRX) a second notice of delisting.
Caris & Co. analyst Linda Bolton Weiser downgraded Sally Beauty Holdings (NYSE: SBH).
Kaufman Bros. downgraded American Superconductor (NYSE: AMSC).
In the broad market, declining issues outpaced advancers by a margin of nearly 8 to 3 on the NYSE and by a margin of more than 4 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks lost 3 points to 613.
